SCYNEXIS Inc (SCYX) stock
SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3071% below fair value
$2.91−0.30 (-9.35%)
Close on Nov 16, 2026Market cap $28.95MP/E –Yield –
Scynexis enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Scynexis's enterprise value was -$37.12M on Nov 11, 2026, against -$8.95M a year earlier. Over the last 5 years it ranged from -$45.16M to $45.37M, with a median of -$24.80M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$37.12M | – |
| 2025 | Dec 31, 2025 | -$11.37M | – |
| 2024 | Dec 31, 2024 | -$38.99M | – |
| 2023 | Dec 29, 2023 | -$22.30M | – |
| 2022 | Dec 30, 2022 | -$45.16M | -199.5% |
| 2021 | Dec 31, 2021 | $45.37M | -14.1% |
| 2020 | Dec 31, 2020 | $52.84M | +31.1% |
| 2019 | Dec 31, 2019 | $40.31M | +89.3% |
| 2018 | Dec 31, 2018 | $21.29M | -70.2% |
| 2017 | Dec 29, 2017 | $71.54M | +21.0% |
| 2016 | Dec 30, 2016 | $59.10M | +81.4% |
| 2015 | Dec 31, 2015 | $32.59M | -36.0% |
| 2014 | Dec 31, 2014 | $50.91M | – |
See a number that looks wrong?